X-twitter Linkedin Facebook-f Vimeo

Health

Companies engaged in biotechnology, pharmaceuticals, research services, home healthcare, hospital operations, long‑term care, and the manufacture and supply of medical equipment and supplies. The sector also includes pharmaceutical retailers and providers of health‑information services. UK‑listed companies in this sector include AstraZeneca plc, GlaxoSmithKline plc, Smith & Nephew plc, Hikma Pharmaceuticals plc, ConvaTec Group plc, Spire Healthcare plc and EMIS Group plc.

Physitrack signs five-year enterprise agreement with UK private hospital group

Physitrack has signed a five-year enterprise agreement worth approximately £255k to deploy more than 400 licences across a UK private hospital group operating more than 30 hospitals...

Physitrack secures £77,000 ARR agreement across 37 UK clinical sites

Physitrack has secured an agreement worth approximately £77,000 in annual recurring revenue, standardising its digital rehabilitation platform across 37 clinical sites and around 400 practitioner licences for a major UK..
Genflow Biosciences Plc

Genflow Biosciences prepares for key longevity data

Genflow Biosciences is set to present full dog longevity study results that could shape its animal health strategy and partnership prospects...
Biotech Growth Trust Plc

Biotech Growth Trust Plc – Annual Report Snapshot 2026

Visit Biotech Growth Trust Plc’s 2026 Annual Report page to review returns, financial highlights, portfolio commentary, KPIs, historic performance and Chair’s statement...
intravenous (IV) line

AstraZeneca and Daiichi Sankyo’s Datroway recommended for EU approval in metastatic TNBC

Astrazeneca Plc says CHMP has recommended Datroway for EU approval as first-line treatment in metastatic triple-negative breast cancer...
VRCI

Verici Dx reports full-year growth in Tutivia revenues and FY25 final results

Verici Dx reported higher annual revenues, first Tutivia sales and continued commercial progress, alongside a post-period equity fundraise...
ETHY

Ethtry reports strengthened balance sheet in 2025 results

Ethtry reported a 2025 loss of £619,270, while cash increased to £4.3 million following a £5.3 million fundraising, supporting its renewable energy strategy and post-year-end Ethereum treasury rollout...
BIOG

Praxis Precision Medicines wins FDA Breakthrough Status for rare epilepsy treatment

Praxis Precision Medicines has received FDA Breakthrough Therapy Designation for elsunersen, adding momentum to a rare epilepsy programme held in Biotech Growth Trust’s portfolio...
Cizzle Biotechnology Holdings plc

Cizzle Bio targets earlier detection in gastric cancer

Cizzle Bio is targeting the gastric cancer diagnostic gap with DEX-G2, a blood test designed to support earlier detection where routine screening is limited...
SPI

Spire Healthcare Group Plc Spire Healthcare receives further extension to PUSU deadline

Spire Healthcare says discussions with Toscafund continue, with the Takeover Panel consenting to a further extension of the offer deadline...
VRCI

Verici Dx secures New York State laboratory certification for Tutivia test

Verici Dx has obtained New York State clinical laboratory certification, completing authorisation for Tutivia across all 50 US states and the District of Columbia...
CIZ

Dr Allan Syms on Cizzle Biotechnology’s CIZ1B US accreditation

Cizzle Biotechnology Executive Chairman Dr Allan Syms discusses the CIZ1B early lung cancer test gaining CLIA accreditation in the US, marking a shift towards commercial adoption, royalty revenues, and wider..
Genflow Biosciences Plc

Healthspan becomes a clearer investment theme in preventive wellness

Healthspan is becoming a stronger investment theme as consumers focus on daily habits that support healthier ageing...
GENF

Genflow Biosciences to Attend BIO San Diego as Chairman Gad Berdugo Joins mRNA Panel

Genflow Biosciences will attend BIO San Diego, with chairman Gad Berdugo joining an mRNA panel...
GSK

GSK gains US FDA approval for oral cUTI antibiotic Utebzi

GSK has secured US FDA approval for Utebzi, an oral carbapenem antibiotic for certain adult patients with complicated urinary tract infections...
Cizzle Biotechnology

Cizzle Biotechnology US Launch Opens the Door to Lung Cancer Test Royalties (video)

Cizzle Biotechnology has reached a pivotal commercial milestone, with its CIZ1B lung cancer blood test now available for clinical use in the United States. Executive Chairman Dr Allan Syms discusses..
SYNC

Syncona appoints Norman Crighton to the Board

Syncona has appointed Norman Crighton as a non-executive director, with committee roles and shareholder priorities outlined...
GENF

Genflow Biosciences to present SLAB study data at Animal Longevity Summit 2026

Genflow Biosciences has been invited to present data from its SLAB study at the Animal Longevity Summit in Toronto in October 2026...
CIZ

Cizzle Biotechnology’s CIZ1B early lung cancer test gains CLIA accreditation in the US

Cizzle Biotechnology’s CIZ1B biomarker blood test has received CLIA accreditation at OmniHealth Diagnostics in Texas, enabling U.S. healthcare providers to order the early-stage lung cancer test...
AZN

Astrazeneca Plc gains US approval for Truqap in PTEN-deficient prostate cancer

Astrazeneca Plc has gained US approval for Truqap with abiraterone and prednisone in PTEN-deficient metastatic prostate cancer...

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

Green News

View all Sustainable sectors, Plcs and news >>  

Search

Search

Latest Interviews

BrokerTalk

Funds

View all Funds, Market Insights and news >> 

FTSE 100 News

UK Broker Ratings

Health

Physitrack signs five-year enterprise agreement with UK private hospital group

Physitrack has signed a five-year enterprise agreement worth approximately £255k to deploy more than 400 licences across a UK private hospital group operating more than 30 hospitals...

Physitrack secures £77,000 ARR agreement across 37 UK clinical sites

Physitrack has secured an agreement worth approximately £77,000 in annual recurring revenue, standardising its digital rehabilitation platform across 37 clinical sites and around 400 practitioner licences for a major UK independent healthcare provider...
Genflow Biosciences Plc

Genflow Biosciences prepares for key longevity data

Genflow Biosciences is set to present full dog longevity study results that could shape its animal health strategy and partnership prospects...
Biotech Growth Trust Plc

Biotech Growth Trust Plc – Annual Report Snapshot 2026

Visit Biotech Growth Trust Plc’s 2026 Annual Report page to review returns, financial highlights, portfolio commentary, KPIs, historic performance and Chair’s statement...
intravenous (IV) line

AstraZeneca and Daiichi Sankyo’s Datroway recommended for EU approval in metastatic TNBC

Astrazeneca Plc says CHMP has recommended Datroway for EU approval as first-line treatment in metastatic triple-negative breast cancer...
VRCI

Verici Dx reports full-year growth in Tutivia revenues and FY25 final results

Verici Dx reported higher annual revenues, first Tutivia sales and continued commercial progress, alongside a post-period equity fundraise...
ETHY

Ethtry reports strengthened balance sheet in 2025 results

Ethtry reported a 2025 loss of £619,270, while cash increased to £4.3 million following a £5.3 million fundraising, supporting its renewable energy strategy and post-year-end Ethereum treasury rollout...
BIOG

Praxis Precision Medicines wins FDA Breakthrough Status for rare epilepsy treatment

Praxis Precision Medicines has received FDA Breakthrough Therapy Designation for elsunersen, adding momentum to a rare epilepsy programme held in Biotech Growth Trust’s portfolio...
Cizzle Biotechnology Holdings plc

Cizzle Bio targets earlier detection in gastric cancer

Cizzle Bio is targeting the gastric cancer diagnostic gap with DEX-G2, a blood test designed to support earlier detection where routine screening is limited...
SPI

Spire Healthcare Group Plc Spire Healthcare receives further extension to PUSU deadline

Spire Healthcare says discussions with Toscafund continue, with the Takeover Panel consenting to a further extension of the offer deadline...
VRCI

Verici Dx secures New York State laboratory certification for Tutivia test

Verici Dx has obtained New York State clinical laboratory certification, completing authorisation for Tutivia across all 50 US states and the District of Columbia...
CIZ

Dr Allan Syms on Cizzle Biotechnology’s CIZ1B US accreditation

Cizzle Biotechnology Executive Chairman Dr Allan Syms discusses the CIZ1B early lung cancer test gaining CLIA accreditation in the US, marking a shift towards commercial adoption, royalty revenues, and wider international licensing opportunities...
Genflow Biosciences Plc

Healthspan becomes a clearer investment theme in preventive wellness

Healthspan is becoming a stronger investment theme as consumers focus on daily habits that support healthier ageing...
GENF

Genflow Biosciences to Attend BIO San Diego as Chairman Gad Berdugo Joins mRNA Panel

Genflow Biosciences will attend BIO San Diego, with chairman Gad Berdugo joining an mRNA panel...
GSK

GSK gains US FDA approval for oral cUTI antibiotic Utebzi

GSK has secured US FDA approval for Utebzi, an oral carbapenem antibiotic for certain adult patients with complicated urinary tract infections...
Cizzle Biotechnology

Cizzle Biotechnology US Launch Opens the Door to Lung Cancer Test Royalties (video)

Cizzle Biotechnology has reached a pivotal commercial milestone, with its CIZ1B lung cancer blood test now available for clinical use in the United States. Executive Chairman Dr Allan Syms discusses the royalty opportunity.....
SYNC

Syncona appoints Norman Crighton to the Board

Syncona has appointed Norman Crighton as a non-executive director, with committee roles and shareholder priorities outlined...
GENF

Genflow Biosciences to present SLAB study data at Animal Longevity Summit 2026

Genflow Biosciences has been invited to present data from its SLAB study at the Animal Longevity Summit in Toronto in October 2026...
CIZ

Cizzle Biotechnology’s CIZ1B early lung cancer test gains CLIA accreditation in the US

Cizzle Biotechnology’s CIZ1B biomarker blood test has received CLIA accreditation at OmniHealth Diagnostics in Texas, enabling U.S. healthcare providers to order the early-stage lung cancer test...
AZN

Astrazeneca Plc gains US approval for Truqap in PTEN-deficient prostate cancer

Astrazeneca Plc has gained US approval for Truqap with abiraterone and prednisone in PTEN-deficient metastatic prostate cancer...
Load More

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

Green News

View all Sustainable sectors, Plcs and news >>  

Search

Search

Latest interviews

Broker Talk

Funds

View all Funds, Market Insights and news >> 

FTSE 100 News

UK Broker Ratings

Health

Latest Interviews

FTSE 100 News

FTSE 250 News

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

BrokerTalk

FTSE 100

Funds

View all Funds, Market Insights and news >> 

Green News

View all Sustainable sectors, Plcs and news >>  

UK Broker Ratings

Follow us on Social Media:

Home X-twitter Linkedin Facebook Spotify Apple